skip to primary navigationskip to content


ideaSpace is a community of people in Cambridge starting high impact new ventures. ideaSpace members are creating new business models which have the potential to benefit millions of people within a few years of start-up.

Read more


With locations in Cambridge’s city centre and on the University’s West Cambridge site, ideaSpace is within walking distance of some of the world’s leading researchers, thinkers, inventors and innovators. It offers flexible membership packages to give you the level of support you need as your business grows.

Read more

Our Community

ideaSpace is part of the University of Cambridge and shares its commitment to making a meaningful contribution to society. While you do not need to belong to the University to join ideaSpace, you should share its aspiration to generate significant social and economic benefits.

Read more

RSS Feed Latest news

Polysolar celebrate Top Innovation Award

Oct 10, 2016

Polysolar who develop, design, and project-manage Building Integrated Photovoltaic (BIPV) solutions have won Cambridge News Top Innovation 2016 Award

Healx secures £1.5m from Amadeus Capital and investors to combat rare diseases

Oct 05, 2016

Amadeus Capital Partners, the global technology investor, has made an early-stage investment of £1.5 million in ideaSpace alumni Healx, a Cambridge based healthcare company that seeks new uses for existing drugs in the fight against rare diseases.

GeneAdviser partners with Birmingham Women’s Hospital to make personalised medicine more accessible

Sep 29, 2016

The largest genetics laboratory in the NHS brings to the platform their solid tumour sequencing, enabling clinicians to give an individual approach to their patients, tailored to their tumour’s genetic makeup.

GeneAdviser raises £350K to boost uptake of genomic medicine

Jun 02, 2016

GeneAdviser, an online ordering platform for clinical genetic testing, has raised £350,000 in its first round of seed funding, backed by Cambridge biotech angel Dr Jonathan Milner.

View all news